The MIT User Center for neutron capture therapy research

Radiation Research

Volumn 164, Issue 2, 2005, Pages 221-229

  Harling, Otto K ^a   Riley, Kent J ^b   Binns, Peter J ^b   Patel, Hemant ^c,d   Coderre, Jeffrey A ^a  

^a Massachusetts Institute of Technology Cambridge   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^d PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CARE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CANCER RESEARCH; CELL CULTURE; DOSIMETRY; HEALTH CARE ACCESS; HEALTH CARE FACILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; LABORATORY DIAGNOSIS; MOUSE; NEUTRON CAPTURE THERAPY; NONHUMAN; PRIORITY JOURNAL; RAT; TECHNOLOGY; THERMAL ANALYSIS;

ANIMALS; BORON; BORON NEUTRON CAPTURE THERAPY; HUMANS; NEUTRON CAPTURE THERAPY; RADIATION DOSAGE;

ANIMALIA;

EID: 22944436179     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/RR3403     Document Type: Article

References (28)

1. D. N. Slatkin, A history of boron neutron capture therapy for brain tumors. Neurosurgery 44, 443-450 (1999).
2. R. F. Barth, Guest Ed., Boron neutron capture therapy: A critical assessment. J. Neuro-Oncol. 62, 1-219 (2003).
3. O. K. Harling and K. J. Riley, Fission reactor neutron sources for neutron capture therapy-a critical review. J. Neuro-Oncol. 62, 7-17 (2003).
4. M. F. Hawthorne and M. W. Lee, A critical assessment of boron target compounds for boron neutron capture therapy. J. Neuro-Oncol. 62, 33-45 (2003).
5. K. J. Riley and O. K. Harling, An improved prompt gamma neutron activation analysis facility using a focused diffracted beam. Nucl. Instrum. Methods B 143, 414-421 (1998).
6. W. Bauer, P. L. Micca and B. M. White, A rapid method for the direct analysis of boron in whole blood by atomic emission spectroscopy. In Advances in Neutron Capture Therapy (A. H. Soloway, R. F. Barth and D. E. Carpenter, Eds.), pp. 403-407. Plenum Press, New York, 1993.
7. R. G. Zamenhof, E. Redmond, II, G. R. Solares, D. Katz, K. J. Riley, W. S. Kiger and O. K. Harling, Monte-Carlo based treatment planning for boron neutron capture therapy using custom designed models automatically generated from CT data. Int. J. Radiat. Oncol. Biol. Phys. 35, 383-397 (1996).
8. D. W. Nigg, Computational dosimetry and treatment planning considerations for neutron capture therapy. J. Neuro-Oncol. 62, 75-86 (2003).
9. J. A. Coderre and G. M. Morris, The radiation biology of boron neutron capture therapy. Radiat. Res. 151, 1-18 (1999).
10. A. D. Chanana, J. Capala, M. Chada, J. A. Coderre, A. Z. Diaz, E. H. Elowitz, J. Iwai, D. D. Joel, H. B. Liu and L. Wielopolski, Boron neutron capture therapy for glioblastoma multiforme: interim results from the Phase I/II dose-escalation studies. Neurosurgery 44, 1182-1193 (1999).
11. P. M. Busse, R. G. Zamenhof, O. K. Harling, I. Kaplan, J. Kaplan, C. F. Chuang, J. T. Goorley, W. S. Kiger, K. J. Riley and M. R. Palmer, The Harvard-MIT BNCT Program: Overview of the clinical trials and translational research. In Frontiers in Neutron Capture Therapy (M. F. Hawthorne, K. Shelley and R. J. Wiersema, Eds.), pp. 37-60. Plenum Press, New York, 2001.
12. P. M. Busse, O. K. Harling, M. R. Palmer, W. S. Kiger, III, J. Kaplan, I. Kaplan, C. F. Chuang, J. T. Goorley, K. J. Riley and R. G. Zamenhof, A critical examination of the results from the Harvard-MIT NCT program phase I clinical trial of neutron capture therapy for intracranial disease. J. Neuro-Oncol. 62, 111-121 (2003).
13. 10B molecule-melanoma cell interaction from in vitro to first clinical trial. Pigment Cell Res. 2, 226-234 (1989).
14. 10B-paraboronophenylalanine with special reference to evaluation of radiation dose and damage to the normal skin. Radiat. Res. 138, 435-442 (1994).
15. S. J. Gonzalez, M. R. Bonomi, G. A. Santa Cruz, H. R. Blaumann, O. A. Calzetta Larrieu, P. Menendez, R. Jimenez-Rebagliati, J. Longhino, D. B. Feld and B. M. C. Roth, First BNCT treatment of a skin melanoma in Argentina: Dosimetric analysis and clinical outcome. Appl. Radiat. Isot. 61, 1101-1105 (2004).
16. T. Pinelli, A. Zonta, S. Altieri, S. Barni, A. Braghieri, P. Pedroni, P. Bruschi, P. Chiari, C. Ferrari and C. Zonta, TAOrMINA: From the first idea to the application to the human liver. In Research and Development in Neutron Capture Therapy (W. Sauerwein, R. Moss and A. Wittig, Eds.), pp. 1065-1072. Monduzzi Editore, Bologna, 2002.
17. H. Hatanaka and Y. Nakagawa, Clinical results of long-surviving brain tumor patients who underwent boron neutron capture therapy. Int. J. Radiat. Oncol. Biol. Phys. 28, 1061-1066 (1994).
18. M. Kouria, L. Kankaanrantaa, T. Seppala, L. Tervob, M. Rasilainenc, H. Minni, O. Eskolaj, J. Vahatalo, A. Paetaud and H. Joensuu, Undifferentiated sinonasal carcinoma may respond to single-fraction boron neutron capture therapy. Radiother. Oncol. 72, 83-85 (2004).
19. I. Kato, K. Ono, Y. Sakurai, M. Ohmae, A. Maruhashi, Y. Imahori, M. Kirihata, M. Nakazawa and Y. Yura, Effectiveness of BNCT for recurrent head and neck malignancies. Appl. Radiat. Isot. 61, 1069-1073 (2004)
20. R. D. Rogus, O. K. Harling and J. C. Yanch, Mixed field dosimetry of neutron beams for neutron capture therapy at the MITR-II research reactor. Med. Phys. 21, 1611-1625 (1994).
21. O. K. Harling, K. A. Roberts, D. J. Moulin and R. D. Rogus, Head phantoms for neutron capture therapy. Med. Phys. 22, 579-583 (1995).
22. 10B in blood after boronophenylalanine-fructose administration in humans. Radiat. Res. 155, 611-618 (2001).
23. O. K. Harling, K. J. Riley, T. H. Newton, B. A. Wilson, J. A. Bernard, L-W. Hu, E. J. Fonteneau, P. T. Menadier, S. J. Ali and P. M. Busse, The fission converter based epithermal neutron irradiation facility at the Massachusetts Institute of Technology Reactor. Nucl. Sci. Eng. 140, 223-240 (2002).
24. K. J. Riley, P. J. Binns and O. K. Harling, Performance characteristics of the MIT fission converter based epithermal neutron beam. Phys. Med. Biol. 48, 943-958 (2003).
25. G. R. Solares and R. G. Zamenhof, A novel approach to the microdosimetry of neutron capture therapy. Part I. High-resolution quantitative autoradiography applied to microdosimetry in neutron capture therapy. Radiat. Res. 144, 50-58 (1995).
26. National Research Council, Guide for the Care and Use of Laboratory Animals, National Academy Press, Washington, DC, 1996.
27. Public Health Service Policy on Humane Care and Use of Laboratory Animals. Office of Laboratory Animal Welfare, National Institutes of Health, Bethesda, MD, 2002.
28. Animal Welfare Act, U.S.C. 7 § 2131-2156, Animal and Plant Health Inspection Service, U.S. Department of Agriculture, Riverdale, MD, 1990.